McKesson Is Roped Into Generic-Drug Price-Fixing Row
By Jeff Overley · September 26, 2018, 10:22 PM EDT
McKesson Corp. earned billions of dollars by cooperating with an industrywide price-fixing conspiracy among generic-drug makers, according to a proposed class action Tuesday that appeared to be one of the first...
To view the full article, register now.